EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization

Maria Byazrova, Pia Gattinger iD, Ekaterina Astakhova, Gerhard Hofer, Musa Khaitov, Alexander Filatov iD, Rudolf Valenta

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Maria Byazrova und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Research Center-Institute of Immunology FMBA of Russia, 115478 Moscow, Russia. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Viravaxx, Megagrant of the Government of the Russian Federation, Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Millions of people have been vaccinated with Gam-COVID-Vac but fine specificities of induced antibodies have not been fully studied. Plasma from 12 naïve and 10 coronavirus disease 2019 (COVID-19) convalescent subjects was obtained before and after two immunizations with Gam-COVID-Vac. Antibody reactivity in the plasma samples (n = 44) was studied on a panel of micro-arrayed recombinant folded and unfolded severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and 46 peptides spanning the spike protein (S) and by immunoglobulin G (IgG) subclass enzyme-linked immunosorbent assay (ELISA). The ability of Gam-COVID-Vac-induced antibodies to inhibit binding of the receptor-binding domain (RBD) to its receptor angiotensin converting enzyme 2 (ACE2) was investigated in a molecular interaction assay (MIA). The virus-neutralizing capacity of antibodies was studied by the pseudo-typed virus neutralization test (pVNT) for Wuhan-Hu-1 and Omicron. We found that Gam-COVID-Vac vaccination induced significant increases of IgG1 but not of other IgG subclasses against folded S, spike protein subunit 1 (S1), spike protein subunit 2 (S2), and RBD in a comparable manner in naïve and convalescent subjects. Virus neutralization was highly correlated with vaccination-induced antibodies specific for folded RBD and a novel peptide (i.e., peptide 12). Peptide 12 was located close to RBD in the N-terminal part of S1 and may potentially be involved in the transition of the pre- to post-fusion conformation of the spike protein. In summary, Gam-COVID-Vac vaccination induced S-specific IgG1 antibodies in naive and convalescent subjects in a comparable manner. Besides the antibodies specific for RBD, the antibodies induced against a peptide close to the N-terminus of RBD were also associated with virus-neutralization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansEpitopesAntibodies, NeutralizingAntibodies, ViralProtein SubunitsSpike Glycoprotein, CoronavirusAntibody FormationImmunoglobulin G

Stichwörter der Autor:innen

COVID-19Gam-COVID-VacOmicronSARS-CoV-2antibodyepitopemolecular interaction assayvirus-neutralization

Substanzen

EpitopesAntibodies, NeutralizingAntibodies, ViralProtein SubunitsSpike Glycoprotein, CoronavirusImmunoglobulin Gspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • National Research Center-Institute of Immunology FMBA of Russia, 115478 Moscow, Russia.
  • Department of Immunology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
  • Department of Immunology, Peoples' Friendship University of Russia (RUDN University) of Ministry of Science and Higher Education of the Russian Federation, 117198 Moscow, Russia.
  • Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Materials and Environmental Chemistry, University of Stockholm, 106 91 Stockholm, Sweden.
  • Department of Immunology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

ORCID-Profile: Pia Gattinger, Alexander Filatov

Förderung

  • Viravaxx
  • Megagrant of the Government of the Russian Federation
  • Russian Science Foundation
  • Viravaxx AG
  • RUDN University Strategic Academic Leadership Program

Zitieren

APA

Byazrova, M., Gattinger, P., Astakhova, E., Hofer, G., Khaitov, M., Filatov, A., & Valenta, R. (2023). Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065104

Vancouver

Byazrova M, Gattinger P, Astakhova E, Hofer G, Khaitov M, Filatov A, et al. Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065104

BibTeX
@article{Byazrova2023,
  author = {Byazrova, Maria and Gattinger, Pia and Astakhova, Ekaterina and Hofer, Gerhard and Khaitov, Musa and Filatov, Alexander and Valenta, Rudolf},
  title = {Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065104}
}
Kostenlos starten →